Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results

FDA's draft guidance for labeling of alpha hydroxy acid-containing products is an interim step taken while the agency continues to evaluate AHAs and their impact on increased skin sensitivity to the sun, FDA says in a Dec. 2 1Federal Register notice